New Mechanisms in Glucose Control

This pocketbook presents a clear overview of the new drugs and treatment therapies that have been developed in recent years to help perfect glycaemic control for the diabetic patient, namely the incretinmimetics (GLP-1 Agonists) and DPP-4 inhibitors. It also considers other drug classes currently in development and undergoing clinical trials, including the SGLT2 inhibitors and other pipeline products. In addition to pharmaceutical treatment therapies, the book covers the role of bariatric surgery as a method of achieving stable glucose levels. To better understand the new treatment therapies, clinicians need to see them in comparison to existing methods, so the book also provides an overview of current diabetes management, including the pros and cons of traditional therapies, and also covers the epidemiology and pathogenesis of type 2 diabetes.

Anthony Barnett, Diabetes Centre, Birmingham Heartlands Hospital, Birmingham, UK

Jenny Grice, Medical Writer, France

1 Epidemiology and pathogenesis of type 2 diabetes.

2 Overview of current diabetes management.

3 The incretin system.

4 The incretin mimetics.

5 The dipeptidyl peptidase 4 inhibitors.

6 Sodium-glucose cotransporter-2 inhibitors.

7 Pipeline diabetes therapies.

8 Bariatric surgery for the treatment of type 2 diabetes.

9 Organisation of diabetes care.

Index.